Visual Analogue Scale - a Quality Assurance Study
Launched by HERLEV HOSPITAL · Sep 15, 2014
Trial Information
Current as of August 11, 2025
Completed
Keywords
ClinConnect Summary
To ensure the data is valid for the study it has been decided to base the research material on four different VAS usage, as it is most often used in clinical practise in Denmark. Which in this case implies VAS horizontal, with and without endpoint, and VAS vertical, with and without endpoint. Every participant will grade their pain on each of the listed VAS representations. Furthermore, as a guideline, the participant will be asked to grade the pain on a Numerical Ranking Scale (NRS).
The ordering of VAS lines will be subject to randomization, for each participant
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patient must have undergone surgery within the last five days
- • The patient must be able and willing to participate in the study
- • Must be at 18 years of age or older
- • A patient can only participate one time.
- Exclusion Criteria:
- • Previously included patients
- • Medically treated patients Linguistic difficulties
- • Mentally or physically exhausted
About Herlev Hospital
Herlev Hospital, a leading healthcare institution located in Denmark, is dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. As a key player in the Danish healthcare system, Herlev Hospital combines cutting-edge facilities with a multidisciplinary approach to research, fostering collaborations among healthcare professionals and researchers. The hospital focuses on a wide range of medical fields, aiming to enhance treatment efficacy and patient care through rigorous scientific inquiry and ethical standards. With a commitment to excellence, Herlev Hospital plays a pivotal role in translating clinical research findings into practical applications that benefit patients and the broader community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Herlev, , Denmark
Herlev, , Denmark
Patients applied
Trial Officials
Jacob Rosenberg, MD
Study Chair
Professor
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials